Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | BlackRock Inc. BLK | 1,869,949 3.400% | -2,729,329 (-59.34%) | Filing History |
| 2024-04-25 5:51 pm Purchase | 2024-04-15 | 13G | Marinus Pharmaceuticals, Inc. MRNS | CITADEL ADVISORS LLC | 222,335 0.400% | 222,335 (New Position) | Filing History |
| 2024-04-19 06:04 am Purchase | 2024-04-16 | 13G | Marinus Pharmaceuticals, Inc. MRNS | TANG CAPITAL PARTNERS LP | 4,502,857 8.200% | 4,502,857 (New Position) | Filing History |
| 2024-02-14 4:18 pm Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Lion Point Capital LP | 2,134,337 3.900% | -2,645,311 (-55.35%) | Filing History |
| 2024-02-14 3:07 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 3,250,000 5.960% | 450,000 (+16.07%) | Filing History |
| 2024-02-14 12:18 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 4,529,997 8.300% | 1,379,997 (+43.81%) | Filing History |
| 2024-02-14 10:35 am Purchase | 2024-02-12 | 13G | Marinus Pharmaceuticals, Inc. MRNS | PRUDENTIAL FINANCIAL INC PRU | 3,309,991 6.070% | 3,309,991 (New Position) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management L.P. | 493,400 0.900% | -3,021,956 (-85.96%) | Filing History |
| 2024-02-14 09:04 am Unchanged | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 3,150,000 5.800% | 0 (Unchanged) | Filing History |
| 2024-02-13 12:13 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 5,463,641 9.990% | 491,981 (+9.90%) | Filing History |
| 2024-02-08 1:56 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | JENNISON ASSOCIATES LLC | 2,959,161 5.400% | 2,959,161 (New Position) | Filing History |
| 2024-02-07 07:25 am Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,581,250 4.730% | -175,000 (-6.35%) | Filing History |
| 2024-02-06 11:58 am Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 3,833,955 7.000% | 3,833,955 (New Position) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | BlackRock Inc. BLK | 4,599,278 8.400% | 3,657,967 (+388.60%) | Filing History |
| 2023-10-10 4:01 pm Purchase | 2023-09-29 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 2,800,000 5.530% | 2,800,000 (New Position) | Filing History |
| 2023-07-06 4:20 pm Purchase | 2023-06-26 | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,756,250 5.450% | 1,293,750 (+88.46%) | Filing History |
| 2023-02-14 4:25 pm Purchase | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management L.P. | 3,515,356 7.100% | 116,695 (+3.43%) | Filing History |
| 2023-02-14 4:15 pm Purchase | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Lion Point Capital LP | 4,779,648 9.900% | 1,150,026 (+31.68%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Venrock Healthcare Capital Partners II L.P. | 1,770,705 3.700% | -1,109,391 (-38.52%) | Filing History |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | 683 Capital Management LLC | 90,000 0.200% | -1,842,829 (-95.34%) | Filing History |